Screener
Prime Medicine PRME EBIT
EBIT at other companies
Other financials
Where this comes from
Calculated from Prime Medicine’s reported figures.
The source filing: Prime Medicine’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:03 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053883
FAQ
- What is Prime Medicine's EBIT?
- Prime Medicine (PRME) reported EBIT of -$43.29M in Q2 2026.
- How has Prime Medicine's EBIT changed year-over-year?
- Prime Medicine's EBIT increased by 18.9% year-over-year, from -$53.38M to -$43.29M.
- What is the long-term trend for Prime Medicine's EBIT?
- Over 3 years (2022 to 2025), Prime Medicine's EBIT has grown at a 21.4% compound annual growth rate (CAGR), from -$116.54M to -$208.35M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Prime Medicine's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude